Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells

Gut

Volumn 45, Issue 4, 1999, Pages 529-536

  Hull, M A ^a,b   Thomson, J L ^a   Hawkey, C J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Cyclooxygenase; Endothelial cell; Gastric mucosa; Gastric ulcer; Prostaglandins

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL ESTER; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL CULTURE; ENDOTHELIUM CELL; GRANULATION TISSUE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ULCER; ULCER HEALING;

EID: 0032880998     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.4.529     Document Type: Article

References (51)

1. Eberhart CE, DuBois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995;109:285-301.
2. Hawkey CJ, Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology 1985;89:1162-88.
3. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:241-9.
4. Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997;100:1325-9.
5. Frolich JC. Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition. Ann Rheton Dis 1995;54:942-3.
6. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993;330:156-60.
7. Mizuno H, Sakamoto C, Matsuda K, et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997;112:387-97.
8. Schmassmann A, Peskar BM, Stettler C, et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 1998;123:795-804.
9. Ferraz JG, Sharkey KA, Reuter BK, et al. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxaemia: role in resistance to damage. Gastroenterology 1997;113:195-204.
10. Iseki S. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem J 1995;27:323-8.
11. Kargman S, Charleson S, Cartwright M, et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 1996;111:445-54.
12. Chen MC, Sanders MJ, Amirian DA, et al. Prostaglandin E, production by dispersed canine fundic mucosal cells; contribution of macrophages and endothelial cells as major sources. J Clin Invest 1989;84:1536-49.
13. Hull MA, Hewett PW, Brough JL, et al. Isolation and culture of human gastric endothelial cells. Gastroenterology 1996;111:1230-40.
14. Maier JA, Voulalas P, Roeder D, et al. Extension of the lifespan of human endothelial cells by an interleukin-1a antisense oligomer. Science 1990;249:1570-4.
15. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8.
16. Morita I, Schindler M, Regier MK, et al. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 1995;270:10902-8.
17. Zembowicz A, Jones SL, Wu KK. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest 1995;96:1688-92.
18. Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 1987;36:2701-11.
19. Nilsen EM, Johansen F-E, Jahnsen FL, et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 1998;42:635-42.
20. Hudson N, Balsitis M, Everitt S, et al. Angiogenesis in gastric ulcers; impaired in patients taking non-steroidal anti-inflammatory drugs. Gut 1995;37:191-4.
21. Lancaster-Smith MJ, Jaderberg MR, Jackson DA. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991;32:252-6.
22. Schmassmann A, Tarnawski A, Peskar BM, et al. Influence of acid and angiogenesis on kinetics of gastrtic ulcer healing in rats: interaction with indomethacin. Am J Physiol 1995;268:G276-85.
23. Jaffe EA, Nachman RL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
24. Kleinman HK, McGarvey ML, Hassell JR, et al. Basement membrane complexes with biological activity. Biochemistry 1986;25:312-18.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
26. Harris RC, McKanna JA, Akai Y, et al. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994;94:2504-10.
27. Vane JR, Mitchell JA, Appleton I, et al. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-50.
28. Zhang F, Warskulat U, Wettstein M, et al. Identification of betaine as an osmolyte in rat liver macrophages (Kupffer cells). Gastroenterology 1996;110:1543-52.
29. Hull MA, Brough JL, Powe DG, et al. Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa. Gut 1998;43:525-36.
30. Futaki N, Takahashi S, Yokohama M, et al. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47:55-9.
31. Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998;95:13313-18.
32. Habib A, Creminon C, Frobert Y, et al. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem 1993;268:23448-54.
33. Madri JA, Pratt BM. Endothelial cell-matrix interactions: in vitro models of angiogenesis. J Histochem Cytochem 1996;34:85-91.
34. Montesano RA, Orci L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 1985;42:469-77.
35. Montesano RA, Orci L. Phorbol esters induce angiogenesis in vitro from large vessel endothelial cells. J Cell Physiol 1987;130:284-91.
36. Mikkelsen HB, Rumessen JJ, Qvortrup K. Prostaglandin H synthase immunoreactivity in human gut. An immunohistochemical study. Histochemistry 1991;96:295-9.
37. Gannon B, Browning J, O'Brien P, et al. Mucosal microvascular architecture of the fundus and body of human stomach. Gastroenterology 1984;86:866-75.
38. Gretzer B, Ehrlich K, Maricic N, et al. Selective cyclooxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br J Pharmacol 1998;123:927-35.
39. Kubota Y, Kleinman HK, Martin GR, et al. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1988;107:1589-98.
40. Morris PB, Hida T, Blackshear PJ, et al. Tumor-promoting phorbol esters induce angiogenesis in vivo. Am J Physiol 1988;254:C318-22.
41. Antonov AS, Lukashev ME, Romanov YA, et al. Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci USA 1986;83:9704-8.
42. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature 1980;288:551-6.
43. Kinsella JL, Grant DS, Weeks BS, et al. Protein kinase C regulates endothelial cell tube formation on basement membrane matrix, Matrigel. Exp Cell Res 1992;199:56-62.
44. Gamble JR, Matthias LJ, Meyer G, et al. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol 1993;121:931-43.
45. Grant DS, Tashiro K-I, Segui-Real B, et al. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989;58:933-43.
46. Reddy ST, Herschman HR. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J Biol Chem 1994;269:15473-80.
47. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
48. Peterson H-I. Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Invasion Metastasis 1983;3:151-9.
49. Benezra D. Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Opthalmol 1978;86:455-61.
50. 1, and copper in angiogenesis. J Natl Cancer Inst 1982;69:475-82.
51. 2 and angiogenesis. Proc Soc Exp Biol Med 1983;172:214-18.